Stem Cell Transplants: More Matches, More Hope — What the ACCESS Study Means

Описание: New findings from the ACCESS study show patients with blood cancers can safely receive stem cell transplants from unrelated donors with multiple HLA mismatches when using post-transplant cyclophosphamide (PTCy). This breakthrough expands donor pools and could make life-saving transplants accessible to nearly everyone, including patients from diverse backgrounds. Learn how a protective regimen reduces GVHD risk, what this means for underrepresented groups, and what’s next for research and clinical practice. If you or a loved one is exploring transplant options, this video breaks down the science in plain language and highlights practical implications for patients and families.